Skip to main content
Top
Published in: Tumor Biology 1/2016

01-01-2016 | Original Article

PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population

Authors: Xu-Dong Yang, Su-Feng Zhao, Qian Zhang, Wei Li, Yu-Xin Wang, Xiao-Wei Hong, Qin-Gang Hu

Published in: Tumor Biology | Issue 1/2016

Login to get access

Abstract

The tumor suppressor gene phosphatase and tensin homologue (PTEN) plays a significant role in regulating cell growth, proliferation, and apoptosis. However, there are no data regarding the role of PTEN polymorphisms in the development of oral squamous cell carcinoma (OSCC). A hospital-based case–control study was conducted to investigate the potential association between PTEN polymorphisms and the risk of OSCC in a Chinese Han population. The study population comprised 201 patients with OSCC and 199 healthy controls. Seventeen single-nucleotide polymorphisms (SNPs) of PTEN were investigated and genotyped using Sequenom Mass ARRAY and iPLEX-MALDI-TOF technology. The observed genotype frequencies of these polymorphisms were in agreement with Hardy-Weinberg equilibrium in the control group (P > 0.05 for all). The heterozygous CT genotype was not associated with significantly increased risk for OSCC (OR = 0.89, 95 % CI = (0.55–1.42), P = 0.83), the TT genotype was not associated with increased risk for OSCC (OR = 1.01, 95 % CI = (0.58–1.74), P = 0.74) compared to the PTEN SNP rs1234224 homozygous CC genotype. Meanwhile, CT/TT variants were not associated with increased risk for OSCC compared with the CC genotype (OR = 0.93, 95 % CI = 0.60–1.44, P = 0.73). The T allele was not associated with significantly increased risk compared to the C allele (OR = 0.99, 95 % CI = 0.72–1.58, P = 0.69). Similar associations with the risk of OSCC were observed for the other genotypes of PTEN gene polymorphisms. There were no significant differences in the distribution of the genotype and allele frequencies of polymorphisms of the PTEN gene between the OSCC patients and controls in a Chinese Han population. Further studies are needed to clarify the specific roles of PTEN polymorphisms in the etiology of OSCC.
Literature
1.
go back to reference Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh EC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011;23(2):237–46.CrossRefPubMed Johnson NW, Warnakulasuriya S, Gupta PC, Dimba E, Chindia M, Otoh EC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res. 2011;23(2):237–46.CrossRefPubMed
2.
go back to reference Petersen PE. Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol. 2009;45:454–60.CrossRefPubMed Petersen PE. Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol. 2009;45:454–60.CrossRefPubMed
3.
go back to reference Robinson PN, Mickelson AR. Early diagnosis of oral cavity cancers. Otolaryngol Clin North Am. 2006;39(2):306.CrossRef Robinson PN, Mickelson AR. Early diagnosis of oral cavity cancers. Otolaryngol Clin North Am. 2006;39(2):306.CrossRef
5.
go back to reference Stadler ME, Patel MR, Couch ME, Hayes DN. Molecular biology of head and neck cancer: risks and pathways. Hematol Oncol Clin North Am. 2008;22:1099–124.CrossRefPubMedPubMedCentral Stadler ME, Patel MR, Couch ME, Hayes DN. Molecular biology of head and neck cancer: risks and pathways. Hematol Oncol Clin North Am. 2008;22:1099–124.CrossRefPubMedPubMedCentral
7.
go back to reference Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum sensitive G1 growth arrest in glioma cells. Cancer Res. 1998;58:5002–8.PubMed Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum sensitive G1 growth arrest in glioma cells. Cancer Res. 1998;58:5002–8.PubMed
8.
go back to reference Davies MA, Koul D, Dhesi H, Berman R, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 1999;59:2551–6.PubMed Davies MA, Koul D, Dhesi H, Berman R, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 1999;59:2551–6.PubMed
9.
go back to reference Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, et al. Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation. Clin Cancer Res. 2007;13(13):3860–7.CrossRefPubMed Bedolla R, Prihoda TJ, Kreisberg JI, Malik SN, Krishnegowda NK, Troyer DA, et al. Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression and Akt activation. Clin Cancer Res. 2007;13(13):3860–7.CrossRefPubMed
10.
go back to reference Westekemper H, Karimi S, Susskind D, Anastassiou G, Freistuhler M, Steuhl KP, et al. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. Br J Ophthalmol. 2011;95(6):853–8.CrossRefPubMed Westekemper H, Karimi S, Susskind D, Anastassiou G, Freistuhler M, Steuhl KP, et al. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma. Br J Ophthalmol. 2011;95(6):853–8.CrossRefPubMed
11.
go back to reference Mao C, Zhou J, Yang Z, Huang Y, Wu X, Shen H, et al. KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer. PLoS One. 2012;7(5):e36653.CrossRefPubMedPubMedCentral Mao C, Zhou J, Yang Z, Huang Y, Wu X, Shen H, et al. KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer. PLoS One. 2012;7(5):e36653.CrossRefPubMedPubMedCentral
12.
go back to reference Chen Q, Samaranayake LP, Zhou H, Xiao L. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol. 2000;36(1):95–9.CrossRefPubMed Chen Q, Samaranayake LP, Zhou H, Xiao L. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol. 2000;36(1):95–9.CrossRefPubMed
13.
go back to reference Mavros A, Hahn M, Wieland I, et al. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med. 2002;31(5):270–6.CrossRefPubMed Mavros A, Hahn M, Wieland I, et al. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med. 2002;31(5):270–6.CrossRefPubMed
14.
go back to reference Carroll BT, Couch FJ. RebbeckTR, Weber BL. Polymorphisms in PTEN in breast cancer families. J Med Genet. 1999;36(2):94–6.PubMedPubMedCentral Carroll BT, Couch FJ. RebbeckTR, Weber BL. Polymorphisms in PTEN in breast cancer families. J Med Genet. 1999;36(2):94–6.PubMedPubMedCentral
15.
go back to reference Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, et al. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis. 2009;30(12):2047–52.CrossRefPubMedPubMedCentral Chen M, Cassidy A, Gu J, Delclos GL, Zhen F, Yang H, et al. Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis. 2009;30(12):2047–52.CrossRefPubMedPubMedCentral
16.
go back to reference Chen J, Shao P, Cao Q, Li P, Li J, Cai H, et al. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. PLoS One. 2012;7(7):e40817.CrossRefPubMedPubMedCentral Chen J, Shao P, Cao Q, Li P, Li J, Cai H, et al. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. PLoS One. 2012;7(7):e40817.CrossRefPubMedPubMedCentral
17.
go back to reference Biolchini F, Pollastri G, Figurelli S, Chiarini L. Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review. Minerva Stomatol. 2005;54:405–14.PubMed Biolchini F, Pollastri G, Figurelli S, Chiarini L. Carcinogen metabolism, DNA damage repair and oral head and neck squamocellular carcinoma (HNSCC). A review. Minerva Stomatol. 2005;54:405–14.PubMed
18.
go back to reference Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 1997;57:2124–9.PubMed Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 1997;57:2124–9.PubMed
19.
go back to reference Sun H, Lesche R, Li DM. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA. 1999;96:6199–204.CrossRefPubMedPubMedCentral Sun H, Lesche R, Li DM. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA. 1999;96:6199–204.CrossRefPubMedPubMedCentral
20.
go back to reference Rahmani A, Alzohairy M, Babiker AY, et al. Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2012;5(9):965–71.PubMedPubMedCentral Rahmani A, Alzohairy M, Babiker AY, et al. Clinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2012;5(9):965–71.PubMedPubMedCentral
21.
go back to reference Squarize CH, Castilho RM, Abrahao AC, et al. PTEN Deficiency Contributes to the Development and Progression of Head and Neck Cancer. Neoplasia. 2013;15(5):461–71.CrossRefPubMedPubMedCentral Squarize CH, Castilho RM, Abrahao AC, et al. PTEN Deficiency Contributes to the Development and Progression of Head and Neck Cancer. Neoplasia. 2013;15(5):461–71.CrossRefPubMedPubMedCentral
22.
go back to reference Snietura M, Jaworska M, Mlynarczyk-Liszka J, et al. PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck. PLoS One. 2012;7(3):e33396.CrossRefPubMedPubMedCentral Snietura M, Jaworska M, Mlynarczyk-Liszka J, et al. PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck. PLoS One. 2012;7(3):e33396.CrossRefPubMedPubMedCentral
24.
go back to reference Ozturk O, Canbay E, Kahraman OT, et al. HER2Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer. Mol Biol Rep. 2013;40:1813–8.CrossRefPubMed Ozturk O, Canbay E, Kahraman OT, et al. HER2Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer. Mol Biol Rep. 2013;40:1813–8.CrossRefPubMed
25.
go back to reference Canbay E, Kahraman OT, Bugra D, et al. Association between PTEN IVS4 polymorphism and development of colorectal cancer in a Turkish population. Expert OpinTher Targets. 2013;17:1–6.CrossRef Canbay E, Kahraman OT, Bugra D, et al. Association between PTEN IVS4 polymorphism and development of colorectal cancer in a Turkish population. Expert OpinTher Targets. 2013;17:1–6.CrossRef
26.
go back to reference Ge H, Cao YY, Chen LQ, et al. PTEN polymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of China. Dis Esophagus. 2008;21:409–15.CrossRefPubMed Ge H, Cao YY, Chen LQ, et al. PTEN polymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of China. Dis Esophagus. 2008;21:409–15.CrossRefPubMed
28.
go back to reference Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25:2433–41.CrossRefPubMed Popanda O, Schattenberg T, Phong CT, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis. 2004;25:2433–41.CrossRefPubMed
29.
go back to reference Schabath MB, Wu X, Wei Q, Li G, Gu J, Spitz MR. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:158–61.CrossRefPubMed Schabath MB, Wu X, Wei Q, Li G, Gu J, Spitz MR. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:158–61.CrossRefPubMed
Metadata
Title
PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population
Authors
Xu-Dong Yang
Su-Feng Zhao
Qian Zhang
Wei Li
Yu-Xin Wang
Xiao-Wei Hong
Qin-Gang Hu
Publication date
01-01-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 1/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3804-5

Other articles of this Issue 1/2016

Tumor Biology 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine